Because of advantages in technology, price and after-sales service, our
products are enjoying high reputation in European countries, America,
Middle East, Southeastern Asia, and so on.
Enhanced External Counter Pulsation (EECP) therapy is a non-invasive mechanical treatment that can help reduce the symptoms of angina, or chest pain. EECP machine popular installed in centers clinic and hospitals. For more details, please email sales-omay@eecpcn.com
EECP was approved by the Food and Drug Administration in 1995 to treat patients with coronary artery disease.It's a noninvasive treatment thaty has been shown to reduce angina pectoris and to extend time to exersise-reduced ischemia in patients with symptoms of stable angina.In addition to relieving myocardial ischemia For more details,please email1
EECP was approved by the Food and Drug Administration in 1995 to treat patients with coronary artery disease.It's a noninvasive treatment thaty has been shown to reduce angina pectoris and to extend time to exersise-reduced ischemia in patients with symptoms of stable angina.In addition to relieving myocardial ischemia For more details,please email1
EECP was approved by the Food and Drug Administration in 1995 to treat patients with coronary artery disease.It's a noninvasive treatment thaty has been shown to reduce angina pectoris and to extend time to exersise-reduced ischemia in patients with symptoms of stable angina.In addition to relieving myocardial ischemia For more details,please email1
EECP machine is a non-invasive treatment,No pain,no side effects for cardiovascular diseases.Portable EECP machine easy and good to operate,good for home use. EECP just like an external heart,two hearts work for patient.Greatly increases blood perfusion and blood supply to vital organs. For more details,please whatsapp:+86-18520667125
EECP treatment can significantly improve coronary blood flow and treat stable angina.Combined with drug therapy,it can promote the formation of coronary collateral vessels,improve coronary blood flow reserve and exercise tolerance in patients with refractory angina.Improve angina sysmptoms and quality of life and most patients continued to benefit 1
EECP was approved by the Food and Drug Administration in 1995 to treat patients with coronary artery disease.It's a noninvasive treatment thaty has been shown to reduce angina pectoris and to extend time to exersise-reduced ischemia in patients with symptoms of stable angina.In addition to relieving myocardial ischemia For more details,please email1
